You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 116 No. 4, April 1981 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS PRESENTED AT THE FOURTH ANNUAL MEETING OF THE ASSOCIATION OF VETERANS ADMINISTRATION SURGEONS, ALEXANDRIA, VA, MAY 11-14, 1980
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Elevated Serum Prolactin Level in the Zollinger-Ellison Syndrome

Bruce E. Stabile, MD; Edward Passaro, Jr, MD; Harold E. Carlson, MD

Arch Surg. 1981;116(4):449-453.


Abstract

• To estimate the prevalence of prolactinoma in the Zollinger-Ellison syndrome (ZES), serum prolactin (PRL) levels were measured by radioimmunoassay in 36 patients with ZES. Eight patients had elevated PRL ievels; however, in one patient the finding was attributed to primary hypothyroidism rather than a prolactinoma. The seven other patients were believed to have previously undiagnosed prolactinomas on the basis of elevated serum PRL levels; the presence of pituitary tumors were confirmed in four by demonstration of sella turcica erosions or enlargement. Serial determinations over three to six years showed a tendency for serum PRL levels to increase modestly in four of six patients. Thus far, two patients have undergone transsphenoidal tumor resections with good results. This study suggests that the prevalence of prolactinoma in patients with ZES is substantial (19% for those with isolated ZES and 54% for those with ZES with multiple endocrine neoplasia, type 1, syndrome), and that early diagnosis is possible with measurement of serum PRL levels. Since levels of PRL tend to increase and clinically significant pituitary tumors can develop, determinations of serial serum PRL levels are recommended for all patients with ZES.

(Arch Surg 1981;116:449-453)



Author Affiliations

From the Surgical Service (Drs Stabile and Passaro) and Endocrinology Section (Dr Carlson), VA Wadsworth Medical Center, and the Departments of Surgery (Drs Stabile and Passaro) and Medicine (Dr Carlson), UCLA School of Medicine, Los Angeles.


Footnotes

Accepted for publication Sept 30, 1980.

Read at the Fourth Annual Surgical Symposium of the Association of Veterans Administration Surgeons, Alexandria, Va, May 13, 1980.

Reprint requests to Surgical Service (691/112K3), VA Wadsworth Medical Center, Los Angeles, CA 90073 (Dr Stabile).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.